DAXI by Revance Coming Soon! Here at Beauty By Dr. Kay, we are always looking to incorporate the newest products and technology, in order to give you the best results, so you can be confident and look your best! DAXI (daxibotulinumtoxinA for Injection), a botulinum toxin type A similar to Botox, Dysport, Xeomin, and Jeuveau, is hoping to become the first neuromodulator to offer longer-lasting wrinkle smoothing results. Once DAXI receives FDA approval for the treatment of frown lines (expected in 2020), it will be the newest neurotoxin on the market! DAXI has been proven as a safe, non-invasive and non-surgical procedure through the largest neuromodulator clinical program ever conducted for treatment of glabellar (frown) lines, as well as showing topline results from clinical trials for use in treating forehead lines and crow’s feet. DAXI could change the wrinkle-relaxer game, as findings from these trials have shown results that last about 6 months on average (2 months longer than its competitors)!
Hi Beauty Byters! On this week’s episode of Beauty Bytes with Dr. Kay: Secrets of a Plastic Surgeon, I am so excited to introduce you all to CEO and Co-Founder of Revance, Dan Browne. Revance has created some buzz recently due in part to their innovative product DAXI (name is subject to change). In this podcast, Dan tells me a little bit about DAXI, the science behind it, and where it stands amongst the toxins that are currently dominating the market. The aesthetics industry is truly witnessing some exciting, new innovations coming to life and interviews like this help bring more awareness to both the good and bad side of things. I ask Dan about the idea of ultrapure toxins and we chat a bit about a type of toxin that requires no needles whatsoever!
Keep up to date on the latest updates, events, podcasts, and exclusive discounts!